相关实验视频

Updated: Jun 10, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

CD103⁺ cDC1 骨髓肉瘤肺转移的树突细胞疫苗疗法

Yuanzheng Yang¹, Yifan Zhou^2,3, Jian Wang⁴

¹Department of Pediatrics Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

|October 16, 2024

概括

这项研究表明,CD103+树突细胞疫苗 (cDCV) 可以缩小骨髓瘤 (OS) 模型中的原发性瘤和肺转移. 将cDCV与抗CTLA-4疗法结合起来,进一步提高了对转移性疾病的有效性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
疫苗开发疫苗开发

背景情况:

骨髓瘤 (OS) 是一种主要的骨癌,对转移的倾向很高.
目前治疗复发性/转移性OS的疗法有效性有限.
需要新的治疗策略来改善晚期OS患者的治疗结果.

研究的目的:

研究由K7M3 OS细胞溶解物衍生的CD103+树突细胞疫苗 (cDCV) 的疗效.
评估cDCV诱导原发性瘤和已确定的肺转移的回归的能力.
评估cDCV治疗后诱导全身免疫反应,包括与抗CTLA-4联合治疗.

主要方法:

用小鼠的双边瘤模型来评估对初级瘤和全身免疫的cDCV治疗.
在K7M3细胞的内注射之后进行截肢和全身cDCV治疗,评估了对已确定的肺转移的疗效.
进行了对瘤,瘤排水淋巴结 (TdLNs) 和脏的免疫细胞分析.
还评估了cDCV与抗CTLA-4的联合治疗.

主要成果:

内cDCV治疗抑制了治疗和未治疗的原发性瘤,增加了T细胞的透.
截肢后的全身cDCV治疗减少了肺转移的大小和数量,并增强了T细胞反应.
结合cDCV与抗CTLA-4药物,显著提高了对肺转移的疗效.

结论:

内cDCV疗法产生系统性免疫反应,控制原发性瘤生长和转移.
系统性cDCV治疗对OS的已建立的肺转移是有效的.
与抗CTLA-4的联合治疗增强了cDCV的疗效,这表明了复发性/转移性OS的潜在新型治疗方法.

关键词:

CD103+ cDC1 树突细胞这是一种抗CTLA-4的药物.抗瘤功效抗瘤功效肺转移是肺的转移.骨质肉瘤是骨质肉瘤的一种疾病.接种疫苗的治疗方法

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...